medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 12

<< Back

Ginecol Obstet Mex 2020; 88 (12)

DRESS syndrome and pregnancy. A case report

Galván-Luna A, Peña-Vega CJ, Torres-Torres J
Full text How to cite this article

Language: Spanish
References: 14
Page: 912-918
PDF size: 193.26 Kb.


Key words:

DRESS syndrome, Pregnancy, Antiepileptic agents, Frontal lobe epilepsy, Carbamazepin, Fever, Erythema, Antihistamines, Paracetamol, Suppurative otitis media, Fetal distress, Cesarean section, Risk factors.

ABSTRACT

Background: DRESS syndrome is a severe, infrequent, and life-threatening toxicodermia.
Clinical case: 17-year-old patient, primitive, diagnosed with frontal lobe epilepsy, treated with 200 mg of carbamazepine every 12 hours. Two months after the beginning of the treatment, exanthema appeared on the face, trunk and abdomen, itching and fever of 38.5 ºC. She was treated with antihistamines and paracetamol, without improvement. She had generalized erythema, hyperkeratotic plaques on face and trunk, stomatitis and suppurative otitis media. She was admitted to the intensive care area with diagnosis of 30 weeks of pregnancy, with single live intrauterine fetus, without labor and dermatosis under study. Multiple discipline care began with the establishment of the diagnosis of DRESS syndrome. Obstetric ultrasound reported: altered fetal hemodynamics and laboratory studies with increased transaminases. It was decided to terminate the pregnancy by cesarean section, indicated by fetal distress and deterioration in the mother’s health conditions, without complications. It continued with the established treatment. Since the clinical evolution was favorable, she was discharged from the service.
Conclusions: Although DRESS syndrome is rare, physicians should be careful in the care of pregnant patients with comorbidities and identify risk factors that may be related to the condition for timely diagnosis and treatment. When patients are properly treated, the syndrome will disappear spontaneously, with limited damage and uncomplicated recovery.


REFERENCES

  1. Bocquet H, et al. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Sem Cutan Med Surg 1996; 15 (4): 250-57. doi: 10.1016/s1085-5629(96)80038-1

  2. Walsh SA, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011; 36 (1): 6-11. doi: 10.1111/j.1365-2230.2010.03967.x.

  3. Sultan SJ, et al. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients. Int J Dermatol 2015; 54 (5): 537-42. doi: 10.1111/ijd.12331.

  4. Muciño J, et al. Síndrome de DRESS. Rev Med Inst Mex Seguro Soc 2013; 51 (3): 330-335. https://www.medigraphic. com/cgi-bin/new/resumen.cgi?IDARTICULO=41731

  5. Picard D, et al. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol 2014; 29 (4): 801-4. doi: 10.1111/jdv.12419.

  6. Descamps V, et al. Síndrome DRESS. EMC-Dermatol 2016; 50 (3): 1-9. http://dx.doi.org/10.1016/S1761- 2896(16)79892-X

  7. Chaiken BH, et al. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950; 242: 897-8. doi: 10.1056/ NEJM195006082422304

  8. Husain Z, et al. DRESS syndrome Part I. Clinical perspectives. J Am Acad Dermatol 2013; 68 (5): 693.e1-693.e14. https:// doi.org/10.1016/j.jaad.2013.01.033

  9. González A, et al. Síndrome Dress. A propósito de un reporte de caso en el Hospital Militar Central. Neuroci Colombia 2015; 22 (4): 301-307. http://www.acncx.org/ images/revistas/pdf/diciembre2015.pdf

  10. Kremić Z, et al. Dress Syndrome - A Case Report. Serbian J Dermatol Venereol 2016; 8 (2): 95-100. https://doi. org/10.1515/sjdv-2016-0009

  11. Londoño H, et al. Síndrome de Dress inducido por anticonvulsivos e insuficiencia hepática fulminante. Rev Fac Med 2017; 65 (1): 165- 168. http://dx.doi.org/10.15446/ revfacmed.v65n1.51919

  12. Sosa A, et al. Síndrome de DRESS: presentación de caso y revisión de literatura. Rev Med Hondur 2017; 85 (3 y 4): 116-119. http://www.bvs.hn/RMH/pdf/2017/pdf/Vol85- 3-4- 2017-12.pdf

  13. Díaz V, et al. Hallazgos clínicos, etiológicos y terapéuticos en la reacción a los medicamentos con síndrome de eosinofilia y síntomas sistémicos (Dress), cuatro años de experiencia en un Hospital Mexicano de tercer nivel. Rev Med Hosp Gen Méx 2016; 79 (2): 55-62. http://dx.doi.org/10.1016/j. hgmx.2015.08.004

  14. Gómez-Cerdas MT, et al. Síndrome de DRESS: abordaje diagnóstico y terapéutico. Rev Med Sinergia 2019; 4 (6):60-72. https://doi.org/10.31434/rms.v4i6.244




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88